期刊名称：ENDOCRINE JOURNAL
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
The Endocrine Journal is the only journal published by the Japan Endocrine Society. It is published 6 times a year and covers basic and clinical endocrinological studies. In recent years, many manuscripts have been submitted by foreign researchers, and the Endocrine Journal is highly evaluated throughout the world.
Publication of Endocrine Journal has partly been supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan.
Instructions to Authors
ENDOCRINE JOURNAL (continuation of ENDOCRINOLOGIA JAPONICA) welcomes submission of unpublished original papers concerned in principle with endocrinology. It is the policy of ENDOCRINE JOURNAL to publish papers which make a contribution either experimentally, theoretically or clinically to knowledge in the field of endocrinology. Only original material including case reports and rapid communications describing new techniques and observations, will be accepted for publication. Papers in English are accepted from any country. Papers should be written in proper English.
The society does not require persons submitting papers to be members of the Japan Endocrine Society, although domestic authors should be members of the Society.
Manuscript Preparation
1. Manuscript types: Original Studies, Notes, Rapid Communications, Reviews and Letters to the Editor (Instructions for Reviews and Letters to the Editor, see below). Original Studies should be original investigative reports. Brief manuscripts reporting data that are preliminary, negative or confirmatory, but have significant relevance should be published as Notes. Rapid Communications of no longer than four printed pages should be of sufficient significance to be published immediately. Note that publishing in Rapid Communications involves an extra charge.
2. Submission of manuscripts: The manuscript must be double-spaced typescript with wide margins. Prenumbered lines in the left margin will facilitate the task of reviewers.
Each manuscript must be accompanied by a letter stating the author's wish that it be reviewed for publication in ENDOCRINE JOURNAL. Authors may suggest the names of appropriate and/or inappropriate reviewers for the reference of the Editorial Board.
One original manuscript and three copies should be submitted to:
Prof. Itaru Kojima Editor-in-Chief
Editorial Office of Endocrine Journal
The Japan Endocrine Society
c/o Kinki Invention Center
14 Yoshida Kawahara-cho, Sakyo-ku, Kyoto 606-8305, Japan (TEL 075-752-2955, FAX 075-752-2963)
3. Titles: Titles should be concise, specific, informative and clear and should emphasize the main point of the article. They should include key words or phrases that are useful for indexing.
4. Authorship: Authorship should be indicated immediately below the title. Include each author's full name and address with postal code of the institution in which the study was done. Persons who made subsidiary contribution may be listed in the 乬Acknowledgements乭. A complete mailing address is given in a footnote on the first page.
5. Running head: Running head not exceeding 40 letters and spaces should be typewritten on the first page.
6. Abstract: An abstract limited to 200 or 250 words should summarize the main points of the article: (1) the purpose of the study, (2) the basic procedures followed, (3) the main findings, and (4) the principal conclusions.
7. Key words: Up to five key words which represent key concepts of the paper should be given at the end of the abstract.
8. Headings: The description of the paper should be made in principle in the following order: Introduction, Materials and Methods, Results, Discussion, Acknowledgements, and References.
9. References: References should be arranged in numerical order in the text and listed in the same numerical order at the end of the manuscript. In the text they should be cited by numbers, e.g. [1, 2-5, 7]. The followings are examples:
1. Imai Y, Odajima R, Shimizu T, Shishiba Y (1990) Serum hyaluronan concentration determined by radiometric assay in patients with pretibial myxedema and Graves' ophthalmopathy. Endocrinol Japon 37: 749-752.
References to chapters in books should be listed as follows:
2. Kato J, Onouchi T (1984) Ovarian steroid hormone receptors in developing rat brain and progesterone modulation of estrogen receptors in the hypothalamus. In: Saxena BB, Catt KJ, Birnbaumer L, Martini L (eds) Hormone Receptors in Growth and Reproduction. Raven Press, New York, vol 9: 279-289.
Reference to abstracts from meetings should be listed as follows:
3. Yanagisawa T, Shirasu K, Uemura T, Minaguchi H (1988) Effects of chronic administration of GnRH analog to the pituitary and the ovary. Program of 8th Inter- national Congress of Endocrinology, Kyoto, Japan, p. 189 (Abstract).
Reference to articles written in Japanese should be translated into English with the author's consent, followed by the ascription, "(In Japanese)", at the end and listed as follows:
4. Suzuki Y, Sugaya S, Matsuoka K, Morinaga S (1989) A case of postperitoneal tumor associated hypoglycemia. Tonyobyo (Diabetes) 32: 628 (Abstract) (In Japanese).
10. Illustrations, photographs, and tables: Illustrations and photographs should be submitted as mounted, highcontrast, glossy prints. It is preferable they be printed in their original size and should be 7.7 cm or 16 cm in width by less than 19 cm in height. The numbers of illustrations and photographs should be marked with a soft pencil on the backside or near to them on the pasteboard . Titles and legends of illustrations and photographs should be typewritten on separate sheets. Tables without vertical lines are preferred. Any explanation essential to the under- standing of the table should be given as a footnote designated by symbols in the order a), b), c)... The site of insertion of figures and tables in the text should be indicated in the right- hand margin of the text.
11. Color photographs: All photographs in one article can be printed in color at the special reduced rate under the following conditions:
1) Photographs are printed in original size; 8 cm or 16 cm in width by less than 19 cm in height. They should be in sharp focus and with good contrast.
2) The number of photographs is unlimited, but the total number of pages should not exceed 8 printed pages.
12. Abbreviations, symbols, and nomenclature: Abbreviations in the body of the paper should be used after having been initially explained. Commonly recognized abbreviations can be used without definition such as yr, h, sec, iv, ip, IU, c, ml, l, SEM, N, M, 亊g, EDTA, cAMP, LATS, etc. Abbreviations for polypeptide hormones other than those listed below must be defined in each article.
ACTH Adrenocorticotropin
CG Chorionic gonadotropin
CRH Corticotropin releasing hormone
CT Calcitonin
FSH Follicle stimulating hormone
GH Growth hormone
GRH GH releasing hormone
LH Luteinizing hormone
LHRH (GnRH) LH releasing hormone
MSH Melanocyte stimulating hormone
PRL Prolactin
PTH Parathyroid hormone
SRIF GH inhibiting factor (Somatostatin)
TSH Thyrotropin
TRH TSH releasing hormone
The metric system of weights and measures, and the 24 hour clock to express time (e.g. 0500 h or 1900 h) should be used.
Drugs should be designated by their generic name. A trade name may be used after a drug has been identified once by its generic name or by its systemic chemical name. Systemic chemical names should conform to the usages given in the indexes of Chemical Abstracts. Nomenclature and symbols except for polypeptide hormones should conform to the recommendations of the International Union of Pure and Applied Chemistry (IUPAC) and the International Union of Biochemistry (IUB). (For reference see J Biol Chem 252: 10, 1977.)
Potency estimates for protein and polypeptide hormones by bioassays, immunoassays, receptor assays, etc., must be expressed in terms of reference preparations such as Inter- national Standards, NIDDK preparations, etc., the nature of which should be described in Materials and Methods. If a suitable recognized standard is not available, a full descrip- tion should be given in the preparation and standardization of the reference materials used.
13. Statistical analyses: Statistical analysis of the data must be done by appropriate methods. Simultaneous comparisons among multiple estimates should be based on the multiple t test, multiple range test or similar techniques that permit these comparisons. Authors should use an appropriate nonparametric test of significance when the data depart substantially from a normal distribution.
For bioassays and competitive protein assays, measures of the precision of the estimates should be given, such as the standard deviation, standard error of the mean, coefficient of variation, or 95亾 confidence limits.
14. Photographic consent: Signed consent forms must be submitted by authors for photographs in which patients can be identified. Masking the eyes does not obviate the need for obtaining permission.
15. Informed consent: To ensure the safety and dignity of human subjects, ENDOCRINE JOURNAL requires that authors state formally in the 乬Materials and Methods乭 section of the manuscript that an appropriate institutional review board approved the experiment, and that informed consent was obtained from the subjects and from parents or legal guardi- ans for minors.
16. Proofs and reprints: The first proofreading is the authors' responsibility. The order form and the price list of reprints will be sent to the authors with the first proof.
17. Page charges: Author(s) must pay page charges of $60 for each page. Color photographsor illustrations charges are $700 for each page. Plate making for figures is chargeable.
18. Copyright: The copyright for articles which appear in ENDOCRINE JOURNAL is held by the Japan Endocrine Society.
Review Articles
ENDOCRINE JOURNAL publishes scholarly review articles in all areas of experimental and clinical endocrinology in each issue. Manuscripts may be solicited by the Editor-in-Chief or proposals for manuscripts may be submitted independently by interested individuals. When submitting a proposal, authors should include the following items: 1. A full outline of the proposed review, listing all topics to be covered. 2. A curriculum vitae for each author. 3.A bibliography of the author's published work. 4. A completion date for the manuscript.
Once a proposal has been reviewed by the Editors, the author will be notified of its status. If accepted, the author will be asked to use the instructions for ordinary papers except that Abstract is not needed. However, a brief summary or conclusion at the end of the manuscript would be helpful to readers. Although the organization of the body of manuscripts is left to the authors, it should be logical and readily comprehended by the reader.
Manuscript should present a timely and authoriative review of a topic in endocrinology that is of general interest. Authors should provide sufficient background information to allow both endocrinologists and other scientists to gain both knowledge and perspective of the subject. While a limited amount of new data may be included to support the author's point of view, manuscripts that deal primarily with new findings should be submitted as ordinary papers. Manuscripts will be reviewed for scientific accuracy, clarity, and balance of perspective by members of the Editorial Board and other experts in the field.
Reviews no longer than ten printed pages are published without page charges. Charges for additional pages, plate making and color illustrations will be quoted on request. Authors will receive fifty reprints without charge.
Letters to the Editor
Letters to the Editor are considered for publication provided they do not contain materials that have been published elsewhere. They are subject to editing and abridgement by the editors, or revision by the author according to the editor's request. Please note the following: 1. The letter must be typewritten and double-spaced. 2. Its text, not including references, must not exceed 500 word. (Please indicate a word count at the end in parenthesis.) 3. The number of authors must be within 5. 4. It must have no more than five references, one figure or table. Letters referring to a recent Endocrine Journal article must be received within six weeks of its publication. Please send your letter by post to the address of the Editorial Board. We will notify you when we have made a decision about publication.
Supplementary Issues
ENDOCRINE JOURNAL may occasionally publish up to two supplementary issues per volume which are distributed to all subscribers of the Journal. One supplementary issue consists usually of 10-20 original and/or review articles under one general title. Manuscript should conform to Manuscript Preparation for usual issues. All the articles are reviewed by the Editorial Board. Those who intend to publish papers in the supplementary issues should organize a group and select a representative. The representative may submit the application to the Editorial Board through the Editor-in-Chief. The application form for the publication of a supplementary issue can be obtained from the Editorial Office. The representative should bear the entire cost of publishing and circulating the supplementary issue if their application is approved by the Editorial Board. The deadline for consideration of application is June 30 each year.
Editorial Board
Editor-in-Chief
Itaru Kojima (Gunma University, Gunma)
Associate Editor-in-Chief
Kazuwa Nakao (Kyoto University, Kyoto)
Masugi Nishihara (The University of Tokyo, Tokyo)
Yuji Taketani (The University of Tokyo, Tokyo)
Takeshi Watanabe (Fukushima Medical University, Fukushima)
Jeffrey D Zajac (The Universisty of Melbourne, Australia)
Editorial Board
Jun Arita (University of Yamanashi,Yamanashi)
Yoshitaka Kajimoto (Osaka University, Osaka)
Susumu Kanzaki (Tottori University ,Tottori)
Shigehiro Katayama (Saitama Medical School, Saitama)
Toshio Matsumoto (The University of Tokushima, Tokushima)
Kaoru Miyamoto (Fukui Medical University, Fukui)
Masatomo Mori (Gunma University, Gunma)
Hirotoshi Nakamura (Hamamatsu University School of Medicine, Shizuoka)
Mitsuhide Naruse (Tokyo Women's Medical University, Tokyo)
Tetsuo Nishikawa (Yokohama Rosai Hospital, Kanagawa)
Tsutomu Ogata (National Research Institute for Child Health and Development, Tokyo)
Akihiko Okuyama (Osaka University, Osaka)
Toshihiro Suda (Hirosaki University, Aomori)
Tositsugu Sugimoto (Kobe University, Hyogo)
Hiroshi Takami (Teikyo University, Tokyo)
Koji Takano (The University of Tokyo, Tokyo)
Yo Takuwa (Kanazawa University, Ishikawa)
Naoki Terakawa (Tottori University, Tottori)
Masaru Wada (Tokyo Medical and Dental University, Chiba)
Toshihiko Yanase (Kyushu University, Fukuoka)
Special Advisory Committee
George Chrousos (National Institutes of Health, U.S.A.)
Orlo H Clark (University of California San Francisco, U.S.A.)
Pavel Hamet (Centre de Recherch Hote-Dieu de Motreal, Canada)
Satya P Kalra (University of Florida, U.S.A.)
Henry M Kronenberg (massachusetts General Hospital, U.S.A.)
Subburaman Mohan (Loma Linda University, U.S.A)
Seymour Reichlin(University of Arizona, U.S.A.)
Yoshimasa Shishiba(Mishuku Hospital Tokyo, Japan)
Evan Simpson(Prince Henry's Institute of Medical Research, Australia)
Jonathan L. Tilly(Massachusetts General Hospital, U.S.A.)
Richard I Weiner(University of California San Francisco, U.S.A.)
Publication Committee of the Japan Endocrine Society
Chief: : Hajime Nawata
Takashi Akamizu, Toshihiro Aono, Kazuo Chihara
Kiyoshi Hashizume, Koichi Hayashi, Yuzuru Kato
Fukuko Kimura, Itaru Kojima, Isamu Miyamori
Yoshiharu Murata, Kazuaki Shimamoto, Hiroshi Takami
Hiroshi Tanaka, Manabu Yoshimura
| 
刊名字顺( Alphabetical List of Journals):
返回页首 